Secreted bacterial phospholipase A2 enzymes: better living through phospholipolysis

Trends in Microbiology

Volumn 15, Issue 2, 2007, Pages 63-69

  Sitkiewicz, Izabela ^a   Stockbauer, Kathryn E ^a   Musser, James M ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; PHOSPHOLIPASE A2; PROTEIN EXOU; PROTEIN SLAA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CLONE; DISEASE SEVERITY; ENZYME RELEASE; GENE TRANSFER; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MEMBRANE COMPONENT; NONHUMAN; PHOSPHOLIPOLYSIS; POPULATION SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION; STREPTOCOCCUS GROUP A;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; BACTERIAL TOXINS; GENE TRANSFER, HORIZONTAL; GENES, BACTERIAL; HUMANS; PHOSPHOLIPASES A; PHOSPHOLIPASES A2; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PYOGENES; VIRULENCE;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS SP. 'GROUP A';

EID: 33846688692     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2006.12.003     Document Type: Article

References (64)

1. 2 as multivalent mediators of inflammatory and allergic disorders. Int. Arch. Allergy Immunol. 131 (2003) 153-163
2. Kumar C.P., et al. Phospholipase and proteinase activities of clinical isolates of Candida from immunocompromised patients. Mycopathologia 161 (2006) 213-218
3. Cox G.M., et al. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol. Microbiol. 39 (2001) 166-175
4. Ganendren R., et al. Phospholipase B activity enhances adhesion of Cryptococcus neoformans to a human lung epithelial cell line. Microbes Infect. 8 (2006) 1006-1015
5. Bhanot P., et al. A surface phospholipase is involved in the migration of plasmodium sporozoites through cells. J. Biol. Chem. 280 (2005) 6752-6760
6. 2-like lytic factor of Trichomonas vaginalis. Infect. Immun. 72 (2004) 1284-1290
7. Sakurai J., et al. Clostridium perfringens α-toxin: characterization and mode of action. J. Biochem. (Tokyo) 136 (2004) 569-574
8. Berka R.M., and Vasil M.L. Phospholipase C (heat-labile hemolysin) of Pseudomonas aeruginosa: purification and preliminary characterization. J. Bacteriol. 152 (1982) 239-245
9. Vasil M.L., et al. Cloning of a phosphate-regulated hemolysin gene (phospholipase C) from Pseudomonas aeruginosa. J. Bacteriol. 152 (1982) 431-440
10. Baine W.B. Cytolytic and phospholipase C activity in Legionella species. J. Gen. Microbiol. 131 (1985) 1383-1391
11. Titball R.W. Bacterial phospholipases C. Microbiol. Rev. 57 (1993) 347-366
12. Scandella C.J., and Kornberg A. A membrane-bound phospholipase A1 purified from Escherichia coli. Biochemistry 10 (1971) 4447-4456
13. Dekker N. Outer-membrane phospholipase A: known structure, unknown biological function. Mol. Microbiol. 35 (2000) 711-717
14. Snijder H.J., and Dijkstra B.W. Bacterial phospholipase A: structure and function of an integral membrane phospholipase. Biochim. Biophys. Acta 1488 (2000) 91-101
15. Tannaes T., et al. Phase variation in the Helicobacter pylori phospholipase A gene and its role in acid adaptation. Infect. Immun. 69 (2001) 7334-7340
16. Tannaes T., et al. Lipid profiles of Helicobacter pylori colony variants. APMIS 108 (2000) 349-356
17. Bukholm G., et al. Colony variation of Helicobacter pylori: pathogenic potential is correlated to cell wall lipid composition. Scand. J. Gastroenterol. 32 (1997) 445-454
18. Istivan T.S., and Coloe P.J. Phospholipase A in Gram-negative bacteria and its role in pathogenesis. Microbiology 152 (2006) 1263-1274
19. Beres S.B., et al. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 10078-10083
20. Kulasekara B.R., et al. Acquisition and evolution of the exoU locus in Pseudomonas aeruginosa. J. Bacteriol. 188 (2006) 4037-4050
21. Sadikot R.T., et al. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 171 (2005) 1209-1223
22. Berthelot P., et al. Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes. J. Infect. Dis. 188 (2003) 512-518
23. Feltman H., et al. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147 (2001) 2659-2669
24. Roy-Burman A., et al. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 183 (2001) 1767-1774
25. Hauser A.R., et al. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit. Care Med. 30 (2002) 521-528
26. Sato H., and Frank D.W. ExoU is a potent intracellular phospholipase. Mol. Microbiol. 53 (2004) 1279-1290
27. Allewelt M., et al. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect. Immun. 68 (2000) 3998-4004
28. Finck-Barbancon V., et al. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 25 (1997) 547-557
29. Hauser A.R., et al. PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence. Mol. Microbiol. 27 (1998) 807-818
30. Kurahashi K., et al. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J. Clin. Invest. 104 (1999) 743-750
31. Pankhaniya R.R., et al. Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU. Crit. Care Med. 32 (2004) 2293-2299
32. Shaver C.M., and Hauser A.R. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect. Immun. 72 (2004) 6969-6977
33. 2 inhibitors. J. Biol. Chem. 278 (2003) 41326-41332
34. Sato H., et al. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J. 22 (2003) 2959-2969
35. Sato H., et al. Characterization of phospholipase activity of the Pseudomonas aeruginosa type III cytotoxin. ExoU. J. Bacteriol. 187 (2005) 1192-1195
36. Sato H., et al. Identification of superoxide dismutase as a cofactor for the pseudomonas type III toxin, ExoU. Biochemistry 45 (2006) 10368-10375
37. Rabin S.D., et al. A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells. Infect. Immun. 74 (2006) 2552-2561
38. Stirling F.R., et al. Eukaryotic localization, activation and ubiquitinylation of a bacterial type III secreted toxin. Cell. Microbiol. 8 (2006) 1294-1309
39. 2+-independent catalytic domain. J. Biol. Chem. 269 (1994) 18239-18249
40. Saliba A.M., et al. Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU. Cell. Microbiol. 7 (2005) 1811-1822
41. Tamura M., et al. Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU. Biochem. Biophys. Res. Commun. 316 (2004) 323-331
42. McMorran B., et al. Effector ExoU from the type III secretion system is an important modulator of gene expression in lung epithelial cells in response to Pseudomonas aeruginosa infection. Infect. Immun. 71 (2003) 6035-6044
43. 2-terminal kinase pathway and increases human epithelial interleukin-8 production. Infect. Immun. 74 (2006) 4104-4113
44. Carapetis J.R., et al. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5 (2005) 685-694
45. Ikebe T., et al. Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive Streptococcus pyogenes M3/T3 isolates in Japan. Infect. Immun. 70 (2002) 3227-3233
46. Nagiec M.J., et al. Analysis of a novel prophage-encoded group A Streptococcus extracellular phospholipase A(2). J. Biol. Chem. 279 (2004) 45909-45918
47. Banks D.J., et al. Prophage induction and expression of prophage-encoded virulence factors in group A Streptococcus serotype M3 strain MGAS315. Infect. Immun. 71 (2003) 7079-7086
48. Shelburne III S.A., et al. Growth characteristics of and virulence factor production by group A Streptococcus during cultivation in human saliva. Infect. Immun. 73 (2005) 4723-4731
49. 2. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 16009-16014
50. Sumby P., et al. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1679-1684
51. Virtaneva K., et al. Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9014-9019
52. Graler M.H., and Goetzl E.J. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim. Biophys. Acta 1582 (2002) 168-174
53. Rosen H., and Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5 (2005) 560-570
54. Zimmerman G.A., et al. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit. Care Med. 30 (2002) S294-S301
55. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
56. Tilley S.L., et al. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108 (2001) 15-23
57. Harizi H., and Gualde N. The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells. Tissue Antigens 65 (2005) 507-514
58. 2 is required for parvovirus infectivity. Dev. Cell 1 (2001) 291-302
59. Farr G.A., et al. Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17148-17153
60. Schmiel D.H., et al. Phospholipase A of Yersinia enterocolitica contributes to pathogenesis in a mouse model. Infect. Immun. 66 (1998) 3941-3951
61. 2 as a pathogenic mechanism in a model of cell injury by typhus and spotted fever group rickettsiae. Am. J. Trop. Med. Hyg. 65 (2001) 936-942
62. Istivan T.S., et al. Characterization of a haemolytic phospholipase A(2) activity in clinical isolates of Campylobacter concisus. J. Med. Microbiol. 53 (2004) 483-493
63. VanRheenen S.M., et al. Members of a Legionella pneumophila family of proteins with ExoU (phospholipase A) active sites are translocated to target cells. Infect. Immun. 74 (2006) 3597-3606
64. Pukatzki S., et al. The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3159-3164